Excedrin (brand)

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This article relies excessively on references to primary sources. Please improve this article by adding secondary or tertiary sources. Find sources: "Excedrin" brand – news · newspapers · books · scholar · JSTOR (August 2013) (Learn how and when to remove this message) This article needs more reliable medical references for verification or relies too heavily on primary sources. Please review the contents of the article and add the appropriate references if you can. Unsourced or poorly sourced material may be challenged and removed. Find sources: "Excedrin" brand – news · newspapers · books · scholar · JSTOR (August 2024) This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Excedrin" brand – news · newspapers · books · scholar · JSTOR (August 2024) (Learn how and when to remove this message) This article contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (August 2013) (Learn how and when to remove this message) This article may require copy editing for grammar, style, cohesion, tone, or spelling. You can assist by editing it. (August 2024) (Learn how and when to remove this message) Some of this article's listed sources may not be reliable. Please help improve this article by looking for better, more reliable sources. Unreliable citations may be challenged and removed. (August 2024) (Learn how and when to remove this message) (Learn how and when to remove this message)

Excedrin is an over-the-counter headache pain reliever, typically in the form of tablets or caplets. It contains paracetamol, aspirin and caffeine. It was manufactured by Bristol-Myers Squibb until it was purchased by Novartis in July 2005 along with other products from BMS's over-the-counter business. As of March 2015, GSK holds majority ownership of Excedrin through a joint venture transaction with Novartis.^[1] On July 18, 2022, GSK spun off its consumer healthcare business (including Excedrin) to Haleon.

The brand became known for advertisements where it cured especially unpleasant and excruciating headaches (called "Excedrin headaches" in the ads of 1970s,^[2] and later called "Excedrin tension headaches"). In 2007, the brand branched out into marketing for other types of pains with the introduction of Excedrin Back & Body, without caffeine.